Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tributylmethylammonium SCHEMBL6657073 | 0.93 | DNM1 (0.38) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL15537851 | 0.92 | DNM1 (0.51) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL7549490 | 0.88 | DNM1 (0.36) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| Tetrabuthylammonium SCHEMBL10643545 | 0.86 | SLC22A1 (0.46) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| Tetrabuthylammonium SCHEMBL14916 | 0.86 | SLC22A1 (0.50) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| Tributylmethylammonium SCHEMBL28955744 | 0.85 | DNM1 (0.46) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL7548020 | 0.84 | SLC22A1 (0.42) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| Tributylmethylammonium SCHEMBL28463343 | 0.83 | SMN1; SMN2 (0.47) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| Tetrapentylammonium SCHEMBL8610604 | 0.82 | SLC22A1 (0.50) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL4351872 | 0.81 | DNM1 (0.56) | DNM1MEN1KMT2AMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5444134-A | Using a coordination catalyst | IDEMITSU KOSAN CO., LTD. (JP) | 1995-08-22 | — | — | US | claimed |
| US-12371828-B2 | CD extensible nonwoven composite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| CN-118223194-A | Soft and durable nonwoven web | 金伯利-克拉克环球有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4385972-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024116789-A1 | LUBRICATING OIL COMPOSITION | 出光興産株式会社 | 2024-06-06 | — | — | WO | disclosed |
| US-20240133091-A1 | CD Extensible Nonwoven Composite | KIMBERLY-CLARK WORLDWIDE, INC. | 2024-04-25 | — | — | US | disclosed |
| EP-3626869-B1 | CRIMPED FIBERS AND NONWOVEN CLOTH | IDEMITSU KOSAN CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2024080214-A1 | METHOD FOR PRODUCING α-OLEFIN POLYMER | 出光興産株式会社 | 2024-04-18 | — | — | WO | disclosed |
| CN-117795038-A | Process for producing alpha-olefin oligomer composition | 出光兴产株式会社 | 2024-03-29 | — | — | CN | disclosed |
| US-5418276-A | Styrene copolymer, syndiotactic, heat resistance, chemical resistance | IDEMITSU KOSAN CO., LTD. (JP) | 1995-05-23 | — | — | US | disclosed |
| US-5369196-A | Production process of olefin based polymers | IDEMITSU KOSAN CO., LTD. (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5362814-A | Styrene polymers with olefin monomers and diolefin monomers for impact strength in molding materials | IDEMITSU KOSAN CO., LTD. (JP) | 1994-11-08 | — | — | US | disclosed |
| EP-0611743-A2 | Process for producing alpha-olefin oligomer compositions | Mitsubishi Chemical Corporation (JP) | 1994-08-24 | — | — | EP | disclosed |
| EP-0591756-A2 | Polymerization catalysts and process for producing polymers | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-04-13 | — | — | EP | disclosed |
| EP-0590486-A2 | Polymerization catalysts and process for producing polymers | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-04-06 | — | — | EP | disclosed |
| EP-0559108-A1 | Graft copolymer, process for production thereof and resin composition containing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-08 | — | — | EP | disclosed |
| EP-0522581-A1 | Process for producing olefin based polymers and olefin polymerization catalyst | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-01-13 | — | — | EP | disclosed |
| EP-0513380-A1 | PROCESS FOR PRODUCING OLEFINIC POLYMER | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-11-19 | — | — | EP | disclosed |
| EP-0504418-A1 | PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER, CYCLOOLEFIN COPOLYMER, AND COMPOSITION AND MOLDING PREPARED THEREFROM | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | OXER1, AMY1A, MACF1 | DNM1 330/4885MEN1 562/4885KMT2A 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.